ASX Announcements

Archive
16 September 2022

New milestone as LCT and OptiCellAI advance AI for NTCELL's manufacture

New milestone as LCT and OptiCellAI advance AI for NTCELL's manufacture, as part of LCT's third clinical trial of NTCELL in Parkinson's disease.

14 September 2022

Receipt of Section 249D Notice

Living Cell Technologies has received a notice pursuant to Section 249D of the Corporations Act 2001.

14 September 2022

Becoming a substantial holder

Notice of initial substantial holder for Living Cell Technologies (ASX:LCT).

9 September 2022

Change of Director's Interests Notice - R Willcocks

Change of Director's Interest Notice for LCT Director Robert Willcocks, who has acquired an additional 500,000 ordinary shares in LCT.

6 September 2022

Notification regarding unquoted securities - LCT

Living Cell Technologies provides notification of the issue of unlisted options under an employee incentive scheme.